Critical Reviews in Oncology/Hematology, 1040-8428

Journal

  1. 2020
  2. 2019
  3. 2018
  4. Clemens, E., van der Kooi, A. L. F., Broer, L., Van Dulmen-den Broeder, E., Visscher, H., Kremer, L., Tissing, W., Loonen, J., Ronckers, C. M., Pluijm, S. M. F., Neggers, S. J. C. M. M., Zolk, O., Langer, T., Zehnhoff-Dinnese, A. A., Wilson, C. L., Hudson, M. M., Carleton, B., Laven, J. S. E., Uitterlinden, A. G., & van den Heuvel-Eibrink, M. M. (2018). The influence of genetic variation on late toxicities in childhood cancer survivors: A review. Critical Reviews in Oncology/Hematology, 126, 154-167. https://doi.org/10.1016/j.critrevonc.2018.04.001
  5. 2017
  6. 2016
  7. De Sanctis, V., Bossi, P., Sanguineti, G., Trippa, F., Ferrari, D., Bacigalupo, A., Ripamonti, C. I., Buglione, M., Pergolizzi, S., Langendijk, J. A., Murphy, B., Raber-Durlacher, J., Russi, E. G., & Lalla, R. V. (2016). Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements. Critical Reviews in Oncology/Hematology, 100, 147-166. https://doi.org/10.1016/j.critrevonc.2016.01.010
  8. 2015
  9. Schindler, A., Denaro, N., Russi, E. G., Pizzorni, N., Bossi, P., Merlotti, A., Bissetti, M. S., Numico, G., Gava, A., Orlandi, E., Caspiani, O., Buglione, M., Alterio, D., Bacigalupo, A., De Sanctis, V., Pavanato, G., Ripamonti, C., Merlano, M. C., Licitra, L., ... Murphy, B. (2015). Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus. Critical Reviews in Oncology/Hematology, 96(2), 372-384. https://doi.org/10.1016/j.critrevonc.2015.06.005
  10. Russi, E. G., Moretto, F., Rampino, M., Benasso, M., Bacigalupo, A., De Sanctis, V., Numico, G., Bossi, P., Buglione, M., Lombardo, A., Airoldi, M., Merlano, M. C., Licitra, L., Denaro, N., Pergolizzi, S., Pinto, C., Bensadoun, R-J., Girolomoni, G., & Langendijk, J. A. (2015). Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus. Critical Reviews in Oncology/Hematology, 96(1), 167-182. https://doi.org/10.1016/j.critrevonc.2015.06.001
  11. 2014
  12. 2013
  13. 2012
  14. Van Gaal, J. C., De Bont, E. S. J. M., Kaal, S. E. J., Versleijen-Jonkers, Y., & van der Graaf, W. T. A. (2012). Building the bridge between rhabdomyosarcoma in children, adolescents and young adults: The road ahead. Critical Reviews in Oncology/Hematology, 82(3), 259-279. https://doi.org/10.1016/j.critrevonc.2011.06.005
  15. 2011
  16. Van Leeuwen, B. L., Rosenkranz, K. M., Feng, L. L., Bedrosian, I., Hartmann, K., Hunt, K. K., Kuerer, H. M., Ross, M., Singletary, S. E., & Babiera, G. V. (2011). The effect of under-treatment of breast cancer in women 80 years of age and older. Critical Reviews in Oncology/Hematology, 79(3), 315-320. https://doi.org/10.1016/j.critrevonc.2010.05.010
  17. 2009
  18. 2007
  19. Corgna, E., Betti, M., Gatta, G., Roila, F., & De Mulder, P. H. M. (2007). Renal cancer. Critical Reviews in Oncology/Hematology, 64(3), 247-261. https://doi.org/10.1016/j.critrevonc.2007.04.007
  20. 2006
  21. 2005
  22. Farshadpour, F., Schaapveld, M., Suurmeijer, AJH., Wymenga, ANM., Otter, R., & Hoekstra, HJ. (2005). Soft tissue sarcoma: why not treated? Critical Reviews in Oncology/Hematology, 54(1), 77-83. https://doi.org/10.1016/j.critrevonc.2004.10.006
  23. 2004
  24. 2003
  25. 2002
  26. 2001
Previous 1 2 Next

ID: 1254770